age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
63.80298
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
under $11k
| 0
| 42,604
| 29,358.1094
| 34,901.3438
| 17.25
|
black
| 25.097656
| 49
| 0.72998
| 0.645996
| 2
| 0
| 0
|
yes
| 0.5
| 0.125
|
no dnr
| 27
| 132
| 5.099609
| 103
| 24
| 36.59375
| 182.5
| 1.299805
| 0.699951
| 9.398438
| 138
| 7.349609
| null | null | null | 2
| 1
|
SIP>=30
| 1
| 201
| 1
|
45.90799
|
male
| 1
| 56
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 133,090
| 87,987.375
| 97,603.75
| 43
|
white
| 32.398438
| 60
| 0.746948
| 0.666992
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 56
| 107
| 24.597656
| 129
| 22
| 38.59375
| 245
| 2.099609
| 9.298828
| 2.699707
| 144
| 7.40918
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 56
| 1
|
63.52597
|
female
| 0
| 83
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 160,341
| 98,017.375
| 112,269.125
| 44
|
white
| 38.398438
| 54
| 0.484985
| 0.366943
| 2
| 0
| 0
|
no
| 0.4
| 0.3
|
no dnr
| 83
| 50
| 22.097656
| 114
| 22
| 38.79688
| 101.42188
| 2.099609
| 1.299805
| 1.599854
| 130
| 7.429688
| null | null | null | null | null | null | 2.589844
| 1,386
| 0
|
42.17697
|
male
| 1
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 9
| 55,616
| 36,861
| 43,872.9375
| 49.333313
|
white
| 23.796875
| 34
| 0.793945
| 0.669922
| 2
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 14
| 73
| 16.796875
| 104
| 12
| 36.19531
| 236.34375
| 1.699951
| 2.5
| 0.699951
| 136
| 7.379883
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
71.50696
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 9
| 19,955
| 13,055.0156
| 15,637.8672
| 15
|
white
| 40.59375
| 54
| 0.343994
| 0.227997
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 16
| 74
| 1.599854
| 58
| 24
| 34.89844
| 53.05469
| 3.399902
| 4
| 1.099854
| 138
| 7.459961
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,386
| 0
|
76.78296
|
female
| 1
| 58
|
Coma
|
Coma
| 0
| 8
|
$11-$25k
| 55
| 138,632
| 85,347.3125
| 98,780.8125
| 37.5
|
white
| 31.199219
| 49
| 0.125
| 0.078995
| 1
| 0
| 0
|
no
| 0.75
| 0.25
|
dnr after sadm
| 26
| 54
| 29.597656
| 99
| 34
| 38.19531
| 225
| 2.599609
| 1
| 2
| 126
| 7.419922
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 58
| 1
|
44.353
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 12
|
$11-$25k
| 100
| 32,768
| 21,883.5156
| 24,289.0312
| 77
|
white
| 55.898438
| 93
| 0
| 0
| 8
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 30
| 45.59375
| 117
| 34
| 36.59375
| 116.92188
| 3
| 3.099609
| 6.5
| 136
| 7.229492
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
64.15295
|
male
| 0
| 50
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 12
|
$11-$25k
| 9
| 120,896
| 80,620.25
| 91,209.75
| 47.5
|
black
| 38.195313
| 73
| 0.369995
| 0.251953
| 9
| 1
| 0
|
no
| 0.99
| 0.970299
|
no dnr
| 50
| 142
| 24
| 134
| 10
| 38.29688
| 168.875
| 1.699951
| 10.099609
| 4.5
| 132
| 7.319336
| null | null | null | null | 5
|
SIP>=30
| 5
| 290
| 1
|
73.15295
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
| null | 0
| 21,349
| 14,302.0547
| 15,387.4375
| 10.5
|
white
| 24.199219
| 40
| 0.707886
| 0.619995
| 12
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 9
| 70
| 14.298828
| 63
| 28
| 36.89844
| 395.1875
| 2.899902
| 0.699951
| 6.699219
| 148
| 7.509766
| null | null | null | null | null |
SIP>=30
| 3.23584
| 1,385
| 0
|
64.92297
|
female
| 1
| 8
|
Lung Cancer
|
Cancer
| 2
| 12
|
under $11k
| 0
| 17,009
| 10,775.4688
| 12,258.6797
| 35
|
white
| 34.796875
| 42
| 0.230988
| 0.025997
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
dnr after sadm
| 7
| 54
| 6.799805
| 101
| 12
| 36.19531
| 194.28125
| 1.899902
| 0.599976
| 1.299805
| 135
| 7.40918
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 8
| 1
|
64.56097
|
male
| 0
| 101
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
| null | 0
| 321,836
| 210,850.75
| 231,331.25
| 50.25
|
white
| 23.199219
| 34
| 0.74292
| 0.662964
| 79
| 1
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 101
| 68
| 23.5
| 128
| 12
| 38.39844
| 215
| 2.5
| 1
| 1.599854
| 134
| 7.399414
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 110
| 1
|
60.19699
|
male
| 0
| 65
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
under $11k
| 0
| 178,996
| 112,564.5
| 126,922.938
| 38.5
|
white
| 23.898438
| 44
| 0.768921
| 0.694946
| 13
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 65
| 142
| 39.296875
| 136
| 14
| 37.79688
| 174
| 2.899902
| 0.799927
| 0.899902
| 142
| 7.459961
| null | null | null | null | 1
|
SIP>=30
| 1
| 970
| 1
|
75.09698
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 1,680
| 1,162.4287
| 1,247.84961
| 7
|
white
| 19.699219
| 25
| 0.833984
| 0.728882
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 3
| 99
| 9.099609
| 93
| 20
| 35.69531
| 338.0625
| null | null | 1.699951
| 142
| 7.449219
| null | null | null | 0
| 0
| null | 0
| 1,383
| 0
|
80.26794
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 44
| 19,288
| 8,867.4922
| 10,029.3594
| 64
|
white
| 91.09375
| 109
| 0
| 0
| 3
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 3
| 0
| 19.398438
| 0
| 0
| 36.69531
| 54
| 2
| 3.599609
| 4.399414
| 130
| 7.149414
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 3
| 1
|
35.98398
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 0
| 11,756
| 7,610.8555
| 8,426.38281
| 16.5
|
white
| 17.5
| 12
| 0.929932
| 0.904907
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 8
| 104
| 13.398438
| 52
| 20
| 38.19531
| 371.375
| 3.399902
| 1.099854
| 0.899902
| 139
| 7.5
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,383
| 0
|
66.62799
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 0
| 9,395
| 6,109.8984
| 7,208.35938
| 18
|
black
| 22.199219
| 29
| 0.825928
| 0.767944
| 1
| 1
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 7
| 116
| 11.798828
| 109
| 12
| 36.59375
| 360
| 3.299805
| 0.5
| 1.5
| 140
| 7.449219
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,380
| 0
|
56.909
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 22,436
| 11,593.8047
| 13,237.9531
| 51
|
white
| 38.09375
| 46
| 0.536987
| 0.422974
| 2
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 8
| 54
| 11
| 115
| 6
| 36.09375
| 106.65625
| null | null | 1.099854
| 126
| 7.5
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
61.55197
|
male
| 1
| 7
|
Coma
|
Coma
| 2
| null | null | 9
| 40,084
| 25,945.5625
| 29,990.4688
| 32
|
white
| 25.699219
| 61
| 0.459961
| 0.386963
| 14
| 0
| 0
|
yes
| 0.5
| 0.2
|
dnr after sadm
| 5
| 103
| 0.699951
| 104
| 36
| 37.79688
| 151
| 2.5
| 0.899902
| 1.799805
| 148
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 2.219238
| 7
| 1
|
36.517
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 0
| 27,843
| 18,594.5625
| 22,851.4688
| 27
|
white
| 40.695313
| 54
| 0.619995
| 0.515991
| 1
| 0
| 0
|
no
| 0.5
| 0.35
|
no dnr
| 15
| 75
| 20.398438
| 129
| 22
| 36
| 200
| 2.799805
| 7.199219
| 5.5
| 128
| 7.429688
| null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 1,377
| 0
|
22.76199
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
$25-$50k
| 9
| 8,681
| 5,767.1133
| 6,647.54688
| 16
|
white
| 23.5
| 18
| 0.901978
| 0.866943
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 6
| 100
| 10.898438
| 118
| 33
| 36.59375
| 385.6875
| 3.699707
| 0.599976
| 0.699951
| 135
| 7.419922
| null | null | null | 0
| 0
| null | 0
| 1,376
| 0
|
47.71298
|
female
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 8,219
| 5,388.7266
| 5,872.59766
| 13
|
black
| 21.398438
| 35
| 0.833984
| 0.728882
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 8
| 85
| 4.799805
| 116
| 24
| 36.5
| 314.25
| 1.099854
| 1.199951
| 1.799805
| 136
| 7.379883
| null | null | null | 6
| 6
|
no(M2 and SIP pres)
| 6
| 970
| 1
|
48.05499
|
male
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
| null | 0
| 97,107
| 64,679.1562
| 71,748.625
| 37
|
black
| 26.5
| 35
| 0.703979
| 0.61499
| 38
| 0
| 0
|
yes
| 0.85
| 0.3
|
dnr after sadm
| 14
| 98
| 23.199219
| 148
| 48
| 38
| 184.4375
| null | null | 1.299805
| 145
| 7.379883
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
77.94098
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 61
| 48,901
| 32,393.4844
| 39,735.9688
| 62
|
white
| 41.898438
| 83
| 0.009998
| 0.002
| 7
| 0
| 0
|
yes
| 0.3
| 0.3
|
dnr after sadm
| 3
| 61
| 11.298828
| 156
| 26
| 35.69531
| 53
| 2
| 6.799805
| 1.399902
| 140
| 7.199219
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 5
| 1
|
90.22595
|
female
| 1
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 8
|
under $11k
| 26
| 8,830
| 5,900.7969
| 6,138.97656
| 15.5
|
white
| 29.597656
| 44
| 0.33197
| 0.145996
| 1
| 0
| 1
|
no
| 0
| 0
|
dnr after sadm
| 1
| 62
| 11.398438
| 118
| 24
| 35.59375
| 192
| 3
| 0.399963
| 0.799927
| 153
| 7.379883
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 10
| 1
|
66.03699
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 3,097
| 2,165.1621
| 2,886.67969
| 17
|
white
| 30
| 38
| 0.554932
| 0.231995
| 1
| 0
| 0
|
metastatic
| 0.2
| 0
|
no dnr
| 5
| 67
| 5.199219
| 114
| 20
| 34.89844
| null | 3.099609
| 0.5
| 1.599854
| 132
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 159
| 1
|
67.86298
|
female
| 1
| 15
|
Coma
|
Coma
| 2
| 8
|
under $11k
| 94
| 29,361
| 19,186.2812
| 21,986.4688
| 38.666657
|
black
| 22.699219
| 32
| 0.243988
| 0.177979
| 1
| 1
| 0
|
no
| 0.02
| 0.000008
|
dnr after sadm
| 8
| 70
| 17.898438
| 144
| 12
| 39.09375
| 225
| 2.5
| 0.599976
| 0.899902
| 131
| 7.459961
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 15
| 1
|
70.59796
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 55
| 49,659
| 33,306.9062
| 38,328.9688
| 69
|
white
| 50.796875
| 81
| 0.009998
| 0.002
| 1
| 1
| 0
|
no
| 0.2
| 0.1
|
no dnr
| 8
| 44
| 16.5
| 116
| 12
| 35.09375
| 105
| 1.299805
| 2.899902
| 4.599609
| 146
| 7.219727
| null | null | null | null | null |
<2 mo. follow-up
| 3.391602
| 8
| 1
|
52.38898
|
female
| 0
| 16
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
| null | 0
| 39,953
| 27,074.7031
| 34,011.0938
| 19.666656
|
white
| 33.195313
| 54
| 0.368958
| 0.250977
| 19
| 0
| 0
|
yes
| 0.95
| 0.9
|
no dnr
| 16
| 61
| 0.069992
| 122
| 24
| 38.79688
| null | 3.099609
| 1.099854
| 2.099609
| 132
| null | null | null | null | null | 2
| null | 2
| 540
| 1
|
63.64999
|
female
| 0
| 16
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 17,688
| 12,061.3438
| 15,700.9844
| 27.333328
|
white
| 36
| 42
| 0.338989
| 0.222992
| 3
| 1
| 0
|
yes
| 0.9
| 0.8
|
dnr after sadm
| 10
| 105
| 2.299805
| 104
| 24
| 36.19531
| null | 3
| 0.599976
| 7.399414
| 123
| null | null | null | null | 2
| null |
<2 mo. follow-up
| 1.839
| 44
| 1
|
84.06598
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 3,843
| 2,547.4453
| 2,624.56836
| 14
|
white
| 18.699219
| 30
| 0.815918
| 0.700928
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 5
| 94
| 9.298828
| 74
| 28
| 36
| 385.6875
| null | null | 1.599854
| 140
| 7.609375
| null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 1,067
| 1
|
46.40097
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 5,005
| 3,216.9316
| 3,474.75977
| 11
|
white
| 25.699219
| 19
| 0.885986
| 0.809937
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 6
| 119
| 27.796875
| 114
| 22
| 36.5
| 537
| null | null | 0.899902
| 128
| 7.419922
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,369
| 0
|
59.14899
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 9
|
under $11k
| 0
| 21,386
| 14,476.8516
| 14,940.1484
| 10.666664
|
black
| 19
| 28
| 0.859985
| 0.810913
| 4
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 16
| 123
| 20
| 100
| 24
| 38
| null | 2.599609
| 0.299988
| 1.799805
| 138
| null | null | null | null | 2
| 3
| null | 3
| 331
| 1
|
47.58899
|
male
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 16
|
>$50k
| 0
| 7,535
| 5,107.9727
| 5,574.01953
| 10
|
white
| 27.199219
| 37
| 0.748901
| 0.603882
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 9
| 110
| 10.699219
| 110
| 22
| 35
| null | 2.899902
| 3.699707
| 1.5
| 135
| null | null | null | null | 2
| 3
|
SIP>=30
| 3
| 1,369
| 0
|
76.96399
|
female
| 1
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$25-$50k
| 0
| 122,608
| 80,382.25
| 90,175.1875
| 38.5
|
white
| 21.898438
| 27
| 0.727905
| 0.643921
| 18
| 1
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 32
| 65
| 21.898438
| 62
| 12
| 36.19531
| 300
| 2.599609
| 0.899902
| 1.5
| 131
| 7.369141
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 32
| 1
|
68.56396
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 12
|
$11-$25k
| 9
| 10,663
| 7,142.5781
| 8,017.66797
| 16
|
white
| 24.796875
| 54
| 0.756958
| 0.679932
| 1
| 1
| 0
|
no
| 0.5
| 0.2
|
no dnr
| 8
| 101
| 11.398438
| 70
| 24
| 36
| 231.40625
| 3.599609
| 0.5
| 6.199219
| 132
| 7.489258
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 56
| 1
|
73.01794
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
under $11k
| 0
| 11,598
| 7,485.3086
| 8,272.59375
| 12.5
|
white
| 19.898438
| 30
| 0.835938
| 0.779907
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 7
| 106
| 27.796875
| 113
| 24
| 36.89844
| 292
| 3.599609
| 0.399963
| 1.099854
| 138
| 7.429688
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,365
| 0
|
41.25897
|
male
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 66,635
| 43,963.4688
| 48,677.625
| 34
|
white
| 19.898438
| 16
| 0.906982
| 0.873901
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 38
| 68
| 13.298828
| 103
| 22
| 38.09375
| 182.5
| 2.899902
| 0.799927
| 0.899902
| 139
| 7.5
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,366
| 0
|
79.04999
|
female
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 10
|
$11-$25k
| 0
| 35,571
| 18,596.2188
| 22,001.7969
| 31.333328
|
white
| 28.097656
| 59
| 0.674927
| 0.503906
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 17
| 65
| 12.199219
| 75
| 32
| 36.19531
| 295
| 2.099609
| 0.5
| 3.5
| 136
| 7.419922
| null | null | null | null | 3
|
SIP>=30
| 3
| 1,366
| 0
|
42.59799
|
male
| 1
| 11
|
Lung Cancer
|
Cancer
| 3
| 12
|
under $11k
| 0
| 51,666
| 33,604.75
| 35,407.0938
| 58.5
|
white
| 53.796875
| 63
| 0.004
| 0
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 8
| 137
| 14
| 113
| 30
| 35.09375
| 55
| 1.099854
| 5.5
| 0.399963
| 134
| 7.399414
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 11
| 1
|
37.073
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 0
| 5,109
| 3,444.1562
| 3,547.12891
| 18
|
white
| 31.199219
| 34
| 0.81897
| 0.705933
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 6
| 86
| 10.798828
| 118
| 22
| 36.69531
| 295.1875
| 2.5
| 0.5
| 2
| 131
| 7.479492
| null | null | null | 0
| null | null | 0.4948
| 76
| 1
|
70.11395
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 7
|
under $11k
| 0
| 3,525
| 2,384.9785
| 2,525.11914
| 8
|
black
| 15.099609
| 30
| 0.893921
| 0.821899
| 1
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 5
| 67
| 4.599609
| 53
| 20
| 36.29688
| 373.75
| 4
| 0.399963
| 1.5
| 137
| 7.439453
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,363
| 0
|
42.08899
|
male
| 0
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 66,406
| 44,127.2188
| 53,441.1562
| 25
|
white
| 28.5
| 37
| 0.521973
| 0.405945
| 24
| 0
| 0
|
yes
| 0.7
| 0.65
|
no dnr
| 21
| 75
| 0.079987
| 77
| 20
| 36.79688
| null | 2.899902
| 2.599609
| 1.099854
| 128
| null | null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 1,363
| 0
|
43.92599
|
male
| 0
| 22
|
Colon Cancer
|
Cancer
| 1
| 10
|
$25-$50k
| 0
| 22,780
| 15,617.7266
| 18,163.6875
| 16
|
white
| 18.296875
| 14
| 0.836914
| 0.642944
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.3
|
dnr after sadm
| 10
| 117
| 10.599609
| 114
| 20
| 36.59375
| null | 3.599609
| 0.899902
| 1
| 136
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 52
| 1
|
69.51996
|
female
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 9
| 10,663
| 7,593.9922
| 7,954.50781
| 5.333332
|
black
| 30.597656
| 47
| 0.567993
| 0.372986
| 1
| 0
| 0
|
yes
| 0.8
| 0.8
|
no dnr
| 17
| 69
| 6.399414
| 120
| 24
| 35
| 276.1875
| 2.5
| 1.099854
| 1.599854
| 141
| 7.509766
| null | null | null | 4
| 5
|
<2 mo. follow-up
| 5
| 21
| 1
|
32.487
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 0
| 12,045
| 8,052.4062
| 8,796.75781
| 18.5
|
white
| 30.796875
| 23
| 0.819946
| 0.758911
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 11
| 103
| 12.099609
| 129
| 24
| 35.09375
| 344.4375
| 3.199707
| 2
| 0.699951
| 129
| 7.519531
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,363
| 0
|
48.00497
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 4,122
| 2,744.3144
| 2,929.08984
| 6
|
black
| 23.898438
| 25
| 0.79895
| 0.675903
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 5
| 97
| 6.899414
| 114
| 20
| 36.69531
| 295.1875
| 2.899902
| 4.5
| 0.799927
| 132
| 7.439453
| null | null | null | 3
| 4
|
no(M2 and SIP pres)
| 4
| 1,363
| 0
|
52.09
|
male
| 0
| 98
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 26
| 146,637
| 97,826.875
| 107,499.812
| 37
|
black
| 30.699219
| 48
| 0.560913
| 0.448975
| 16
| 0
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 98
| 142
| 38.898438
| 68
| 10
| 36.5
| 134
| 3.199707
| 1.399902
| 2.599609
| 155
| 7.399414
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 841
| 1
|
61.92999
|
male
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 6
|
under $11k
| 9
| 20,880
| 12,499.5859
| 13,685.4453
| 21
|
white
| 29.699219
| 42
| 0.720947
| 0.564941
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 12
| 117
| 9.599609
| 133
| 48
| 35.5
| 195.8125
| 3.299805
| 1.399902
| 0.799927
| 137
| 7.359375
| null | null | null | 2
| 1
|
<2 mo. follow-up
| 1
| 56
| 1
|
80.39398
|
male
| 0
| 19
|
Coma
|
Coma
| 2
| 8
| null | 55
| 17,833
| 12,272.9688
| 14,538.4531
| 17.666656
|
white
| 23.5
| 34
| 0.293945
| 0.223999
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 2
| 144
| 18.097656
| 120
| 24
| 38
| null | null | 1.099854
| 1.299805
| 129
| 7.469727
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 40
| 1
|
32.51199
|
male
| 1
| 32
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 91,929
| 60,005.625
| 72,041.3125
| 42.5
|
white
| 43
| 64
| 0.442993
| 0.241974
| 5
| 0
| 0
|
no
| 0.6
| 0.4
|
dnr after sadm
| 19
| 73
| 36.09375
| 104
| 22
| 36.29688
| null | 2.299805
| 35.796875
| 3.099609
| 129
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 32
| 1
|
68.83496
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| 16
|
>$50k
| 0
| 3,619
| 2,349.4531
| 2,504.66992
| 11
|
white
| 11.599609
| 26
| 0.793945
| 0.564941
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 77
| 11.699219
| 85
| 20
| 36.79688
| null | 4
| 0.5
| 1.699951
| 137
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.365234
| 347
| 1
|
36.94699
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 18
|
under $11k
| 0
| 18,359
| 12,018.5
| 16,215.0391
| 29.5
|
black
| 37.296875
| 69
| 0.69397
| 0.601929
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 9
| 153
| 11
| 44
| 40
| 35.89844
| 102.84375
| 2.299805
| 4.899414
| 1.5
| 135
| 7.389648
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,356
| 0
|
71.55597
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 6
|
under $11k
| 0
| 3,269
| 2,109.3984
| 2,277.51953
| 11
|
hispanic
| 26.097656
| 36
| 0.75293
| 0.609985
| 1
| 1
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 4
| 53
| 4.899414
| 62
| 22
| 35.39844
| 285.6875
| 3.399902
| 1.399902
| 1
| 130
| 7.429688
| null | null | null | 2
| null |
SIP>=30
| 1.839
| 481
| 1
|
81.45898
|
female
| 0
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 7,343
| 4,772.5156
| 5,694.40625
| 18
|
white
| 28
| 21
| 0.472961
| 0.353943
| 2
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr before sadm
| -1
| 83
| 22.898438
| 112
| 24
| 35.69531
| null | null | null | 0.599976
| 129
| null | null | null | null | 0
| 2
|
no(M2 and SIP pres)
| 2
| 120
| 1
|
24.44399
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
under $11k
| 0
| 11,039
| 7,373.1641
| 7,918.89844
| 17.5
|
black
| 20.597656
| 37
| 0.928955
| 0.901978
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 8
| 68
| 20.097656
| 120
| 28
| 38.89844
| 376.1875
| 2.399902
| 0.5
| 1
| 140
| 7.419922
| null | null | null | 2
| 1
|
no(M2 and SIP pres)
| 1
| 1,352
| 0
|
79.35699
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
under $11k
| 0
| 2,569
| 1,768.1455
| 1,901.43945
| 11
|
white
| 25.199219
| 30
| 0.731934
| 0.580933
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 4
| 85
| 6.399414
| 50
| 20
| 36.39844
| null | null | 0.399963
| 2.399902
| 129
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 1,352
| 0
|
76.93097
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 44
| 4,166
| 2,688.6777
| 2,902.7793
| 17
|
white
| 17.199219
| 28
| 0.719971
| 0.562988
| 1
| 0
| 1
|
no
| 0.7
| 0.8
|
dnr after sadm
| 1
| 105
| 12.099609
| 112
| 22
| 36.29688
| 248
| 4
| 0.399963
| 1.199951
| 145
| 7.429688
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 202
| 1
|
56
|
male
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 26,670
| 14,787.7266
| 16,474.625
| 22.333328
|
hispanic
| 23.398438
| 51
| 0.851929
| 0.755981
| 1
| 0
| 0
|
no
| 0.25
| 0.2
|
no dnr
| 14
| 73
| 11.199219
| 125
| 31
| 38
| 130
| 4.199219
| 1.299805
| 1.199951
| 134
| 7.489258
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,350
| 0
|
28.47099
|
male
| 0
| 25
|
Colon Cancer
|
Cancer
| 1
| 18
|
$25-$50k
| 0
| 24,310
| 16,874.4062
| 17,812.5781
| 12
|
white
| 16
| 5
| 0.882935
| 0.733887
| 1
| 0
| 0
|
metastatic
| 1
| 0.75
|
no dnr
| 25
| 96
| 10.599609
| 74
| 20
| 37.69531
| null | 3.599609
| 0.399963
| 0.699951
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 235
| 1
|
37.254
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
under $11k
| 0
| 15,118
| 10,010.7344
| 11,255.7344
| 18.5
|
white
| 27.199219
| 33
| 0.849976
| 0.797974
| 1
| 0
| 0
|
no
| 0.99
| 0.9
|
no dnr
| 9
| 76
| 33.398438
| 118
| 32
| 38.39844
| 286.625
| 2.799805
| 3.299805
| 0.699951
| 130
| 7.429688
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,351
| 0
|
55.16498
|
male
| 1
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
$11-$25k
| 0
| 122,472
| 80,453
| 90,847.75
| 51.5
|
white
| 36.398438
| 60
| 0.537964
| 0.422974
| 7
| 0
| 0
|
no
| 0.7
| 0.8
|
dnr after sadm
| 28
| 53
| 18.597656
| 117
| 29
| 39.19531
| 145
| 1.799805
| 5.299805
| 1.299805
| 148
| 7.389648
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 30
| 1
|
55.81699
|
female
| 0
| 98
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
under $11k
| 55
| 169,530
| 109,842.25
| 123,437.062
| 45
|
white
| 30
| 29
| 0.454956
| 0.335999
| 5
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 98
| 71
| 15.898438
| 114
| 12
| 36
| 111.65625
| 2.199707
| 0.5
| 0.599976
| 142
| 7.469727
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 116
| 1
|
60.34799
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 10
|
$11-$25k
| 0
| 3,128
| 2,014.3809
| 2,215.19922
| 4
|
white
| 15.599609
| 15
| 0.744995
| 0.481995
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 78
| 6.799805
| 98
| 20
| 36.09375
| null | 3.599609
| 0.199982
| 1
| 135
| null | null | null | null | null | null |
SIP>=30
| 2.347168
| 205
| 1
|
76.89496
|
male
| 0
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 19
| null | 9
| 29,263
| 19,455.6406
| 23,673.1875
| 23.333328
|
white
| 23.398438
| 35
| 0.594971
| 0.487
| 6
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr before sadm
| -5
| 89
| 0.179993
| 71
| 22
| 38.09375
| null | null | null | 1.399902
| 135
| null | null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 26
| 1
|
57.55798
|
female
| 1
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 9
| 91,058
| 59,330.0938
| 66,847
| 53
|
white
| 37.296875
| 53
| 0.242981
| 0.140991
| 20
| 0
| 0
|
metastatic
| 0.5
| 0.5
|
no dnr
| 25
| 61
| 15.199219
| 132
| 28
| 37.59375
| 106.65625
| 1.299805
| 5.5
| 0.699951
| 130
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 25
| 1
|
67.87396
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 7
|
under $11k
| 0
| 19,872
| 13,052.7031
| 14,565.9141
| 20
|
hispanic
| 17.5
| 18
| 0.843994
| 0.789917
| 1
| 0
| 0
|
yes
| 0.7
| 0.6
|
no dnr
| 13
| 114
| 11.599609
| 67
| 30
| 36.59375
| 380
| 2.899902
| 0.5
| 0.899902
| 139
| 7.529297
| null | null | null | 1
| 1
|
<2 mo. follow-up
| 1
| 36
| 1
|
76.745
|
female
| 0
| 74
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
under $11k
| 0
| 155,280
| 99,237.875
| 114,867.625
| 42.25
|
white
| 20.699219
| 31
| 0.725952
| 0.641968
| 5
| 0
| 0
|
yes
| 0.9
| 0.5
|
no dnr
| 74
| 58
| 29.597656
| 71
| 10
| 39.09375
| 166.65625
| 2.199707
| 0.699951
| 0.799927
| 141
| 7.439453
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 185
| 1
|
71.29895
|
male
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
| null | 9
| 13,484
| 7,040.2148
| 8,658.79688
| 27
|
white
| 23.796875
| 35
| 0.723999
| 0.638916
| 4
| 0
| 0
|
no
| 0.9
| 0.6
|
dnr after sadm
| 3
| 81
| 9.199219
| 138
| 20
| 36.59375
| 283.3125
| 2.899902
| 0.299988
| 8.398438
| 135
| 7.429688
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 134
| 1
|
57.71698
|
female
| 0
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 5,169
| 3,299.7637
| 4,360.33984
| 17
|
white
| 31.199219
| 37
| 0.453979
| 0.333984
| 1
| 0
| 0
|
metastatic
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 116
| 2.399902
| 118
| 20
| 36.39844
| null | 2.699707
| 0.799927
| 5.699219
| 138
| null | null | null | null | 5
| 6
|
<2 mo. follow-up
| 6
| 14
| 1
|
41.306
|
male
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 14
|
under $11k
| 0
| 7,684
| 5,010.5156
| 5,581.61719
| 11
|
white
| 27.296875
| 48
| 0.784912
| 0.655884
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 8
| 101
| 10.298828
| 110
| 20
| 37.89844
| 338.0625
| 3
| 9.398438
| 0.599976
| 132
| 7.519531
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,342
| 0
|
48.51999
|
female
| 0
| 7
|
Coma
|
Coma
| 0
| 16
|
$25-$50k
| 61
| 9,025
| 6,035.9375
| 7,317.09766
| 30
|
white
| 21
| 13
| 0.643921
| 0.583984
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 7
| 109
| 18.097656
| 62
| 27
| 36.29688
| 596.25
| 4.299805
| 0.199982
| 0.599976
| 145
| 7.40918
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 1,342
| 0
|
30.70799
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 4,510
| 2,412.8984
| 3,071.56836
| 11
|
black
| 23.398438
| 29
| 0.911987
| 0.851929
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 4
| 79
| 3.599609
| 110
| 22
| 35.79688
| 446.625
| 3.599609
| 1.599854
| 1.699951
| 133
| 7.539062
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 250
| 1
|
68.29596
|
female
| 1
| 5
|
Coma
|
Coma
| 0
| null | null | 100
| 133,305
| 88,152.25
| 97,472.125
| 55
|
white
| 25.597656
| 21
| 0.052994
| 0.028
| 68
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 121
| 11.599609
| 138
| 12
| 35.29688
| 212.5
| 2.599609
| 0.5
| 1.199951
| 150
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 2.839844
| 5
| 1
|
57.98999
|
male
| 0
| 18
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 8
| null | 9
| 40,193
| 26,652.375
| 31,694.9688
| 41
|
white
| 24.296875
| 30
| 0.665894
| 0.491943
| 3
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 18
| 81
| 22.796875
| 73
| 28
| 36
| null | 2.299805
| 3.799805
| 0.599976
| 134
| null | null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 46
| 1
|
86.22595
|
female
| 0
| 7
|
Coma
|
Coma
| 1
| 12
| null | 37
| 17,560
| 9,003.4609
| 10,698.1562
| 25.5
|
white
| 21.097656
| 28
| 0.348999
| 0.27594
| 3
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 3
| 128
| 14.898438
| 54
| 24
| 38
| 370
| 3.099609
| 0.899902
| 2.399902
| 137
| 7.479492
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 8
| 1
|
85.35498
|
female
| 0
| 161
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 10
|
under $11k
| 9
| 281,985
| 181,805.75
| 217,365.125
| 50.5
|
white
| 34.09375
| 49
| 0.151978
| 0.072998
| 23
| 0
| 1
|
metastatic
| 0.7
| 0.6
|
no dnr
| 161
| 53
| 21.199219
| 137
| 36
| 37.79688
| 142.21875
| null | null | 1.199951
| 132
| 7.459961
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 311
| 1
|
44.25699
|
female
| 0
| 13
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 12,040
| 8,074.7148
| 10,061.9297
| 15.5
|
white
| 25.398438
| 24
| 0.570923
| 0.248993
| 1
| 0
| 0
|
metastatic
| 0.2
| 0
|
dnr after sadm
| 1
| 85
| 1.899902
| 76
| 12
| 35.89844
| 342.8125
| 3.099609
| 0.699951
| 0.599976
| 131
| 7.519531
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 20
| 1
|
52.14798
|
female
| 0
| 59
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 16
| null | 0
| 174,127
| 113,074.812
| 134,350.5
| 46.5
|
white
| 35.898438
| 81
| 0.293945
| 0.182983
| 17
| 1
| 0
|
yes
| 0.8
| 0.8
|
no dnr
| 59
| 58
| 0.069992
| 141
| 32
| 39
| 215
| 2.799805
| 0.799927
| 1.599854
| 155
| 7.419922
| null | null | null | null | 0
| null | 0
| 72
| 1
|
47.79498
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 14,875
| 9,237.9219
| 11,169.1562
| 19.5
|
white
| 26
| 37
| 0.8479
| 0.75
| 1
| 0
| 0
|
no
| 0.99
| 0.8
|
no dnr
| 10
| 113
| 18.097656
| 118
| 28
| 36.09375
| 323.75
| 3.899902
| 0.5
| 1.5
| 125
| 7.399414
| null | null | null | 2
| 2
|
no(M2 and SIP pres)
| 2
| 1,339
| 0
|
74.56494
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
$11-$25k
| 0
| 66,352
| 46,258.3125
| 51,358.9062
| 40
|
white
| 28.699219
| 52
| 0.572998
| 0.461975
| 52
| 0
| 1
|
no
| 0
| 0
|
dnr before sadm
| -1
| 57
| 9.5
| 130
| 32
| 35.39844
| 290
| 1.5
| 0.799927
| 0.399963
| 142
| 7.529297
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 4
| 1
|
39.45798
|
male
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 11
|
under $11k
| 0
| 7,043
| 4,771.7617
| 5,061.45703
| 5
|
hispanic
| 24.597656
| 32
| 0.831909
| 0.724976
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 8
| 111
| 11.398438
| 96
| 20
| 36.59375
| null | 2.5
| 0.399963
| 3.899902
| 132
| null | null | null | null | 5
| 3
|
no(M2 and SIP pres)
| 3
| 1,172
| 1
|
61.31097
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 10
|
$11-$25k
| 0
| 4,140
| 2,697.5898
| 2,850.92969
| 8
|
white
| 9.199219
| 17
| 0.838989
| 0.646973
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.2
|
no dnr
| 3
| 97
| null | 101
| 22
| 36.29688
| null | 4.299805
| 0.5
| 1.399902
| 135
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 218
| 1
|
81.224
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 10
|
under $11k
| 0
| 4,326
| 2,747.2949
| 3,274.95898
| 12
|
white
| 13.099609
| 35
| 0.830933
| 0.724976
| 1
| 0
| 0
|
yes
| 0.75
| 0.5
|
dnr after sadm
| 1
| 75
| 3.599609
| 70
| 20
| 35.79688
| 204.75
| 4.399414
| 0.699951
| 0.699951
| 136
| 7.299805
| null | null | null | 1
| 1
|
<2 mo. follow-up
| 1
| 30
| 1
|
68.78296
|
male
| 1
| 22
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 0
| 70,108
| 46,481.1875
| 53,040.7812
| 35.666657
|
white
| 27.796875
| 38
| 0.517944
| 0.317993
| 3
| 1
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 21
| 71
| 12.798828
| 106
| 26
| 36.79688
| 259.25
| 2.899902
| 7.399414
| 1
| 131
| 7.449219
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 22
| 1
|
85.41498
|
male
| 1
| 4
|
Coma
|
Coma
| 3
| 8
|
under $11k
| 61
| 11,734
| 7,946.3281
| 8,816.02344
| 32
|
white
| 49.59375
| 68
| 0
| 0
| 4
| 0
| 1
|
no
| 0
| 0
|
dnr after sadm
| 1
| 36
| 13
| 46
| 32
| 39.5
| 98.32812
| 2.799805
| 0.599976
| 5.099609
| 136
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 5.583008
| 4
| 1
|
77.125
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 3,972
| 2,723.7598
| 2,939.7793
| 9
|
white
| 16.398438
| 27
| 0.86499
| 0.775879
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 6
| 67
| 4.899414
| 100
| 22
| 36.19531
| null | 3.799805
| 1.699951
| 1.199951
| 136
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 193
| 1
|
76.22198
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 26,270
| 17,649.9688
| 20,025.2969
| 16
|
white
| 23.097656
| 26
| 0.745972
| 0.665894
| 4
| 0
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 17
| 113
| 15.298828
| 60
| 28
| 37.59375
| 144.875
| 3.599609
| 1
| 0.899902
| 141
| 7.439453
| null | null | null | 5
| null |
SIP>=30
| 3.855299
| 1,330
| 0
|
50.702
|
male
| 0
| 19
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 27,858
| 17,403.3281
| 19,633.4375
| 18.666656
|
white
| 21.796875
| 26
| 0.902954
| 0.835938
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 19
| 110
| 24.199219
| 120
| 32
| 36.39844
| 145.6875
| 3.599609
| 0.799927
| 0.899902
| 144
| 7.379883
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 968
| 1
|
74.81696
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 10
|
under $11k
| 0
| 10,632
| 6,724.168
| 7,052.36719
| 20.5
|
black
| 30.398438
| 49
| 0.620972
| 0.435974
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 10
| 107
| 15.599609
| 111
| 38
| 36.19531
| 164.5
| 3.299805
| 0.599976
| 1.899902
| 138
| 7.339844
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,328
| 0
|
77.57397
|
female
| 0
| 18
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 15
| null | 26
| 68,899
| 45,641.6875
| 51,858.5312
| 23.666656
|
white
| 27.699219
| 50
| 0.34198
| 0.225983
| 23
| 0
| 0
|
yes
| 0.25
| 0.1
|
dnr after sadm
| 3
| 131
| 0.089996
| 76
| 24
| 39.39844
| null | 3.199707
| 1.699951
| 1.699951
| 132
| null | null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,328
| 0
|
66.77899
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 33,506
| 21,843.0625
| 23,683.7969
| 50
|
white
| 40.195313
| 53
| 0.375
| 0.255981
| 4
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 5
| 126
| 28
| 130
| 30
| 35.39844
| 138
| 2
| 3.099609
| 0.5
| 127
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
65.13898
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 4
| null | 0
| 4,045
| 2,666.4102
| 2,842.74805
| 11
|
white
| 10.099609
| 20
| 0.93689
| 0.891968
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 5
| 104
| 4.799805
| 77
| 28
| 36.79688
| 328
| 4.399414
| 1.099854
| 0.799927
| 140
| 7.389648
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,326
| 0
|
61.435
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| 21,128
| 13,303.3438
| 15,684.6484
| 32.5
|
white
| 26.796875
| 24
| 0.79895
| 0.67688
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 11
| 74
| 35
| 126
| 10
| 36.59375
| 240
| 2.799805
| 0.5
| 0.599976
| 144
| 7.339844
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,325
| 0
|
45.89999
|
female
| 0
| 17
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 16
|
under $11k
| 9
| 15,710
| 10,601.0859
| 12,727.1484
| 19.666656
|
white
| 29.699219
| 44
| 0.680908
| 0.510986
| 1
| 0
| 0
|
no
| 0.7
| 0.343
|
no dnr
| 17
| 78
| 10.099609
| 110
| 24
| 37.79688
| 338.0625
| 2.799805
| 30
| 0.799927
| 134
| 7.479492
| null | null | null | 4
| 0
|
adl>=4 (>=5 if sur)
| 0
| 90
| 1
|
29.073
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$25-$50k
| 0
| 4,748
| 3,073.3691
| 3,483.26953
| 10
|
white
| 14.699219
| 13
| 0.956909
| 0.92688
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 5
| 79
| 14.199219
| 79
| 22
| 37
| 380.9375
| 3.899902
| 2.199707
| 0.899902
| 134
| 7.429688
| null | null | null | null | null |
no(M2 and SIP pres)
| 1.852051
| 1,237
| 1
|
28.81299
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 54,911
| 35,893.0938
| 39,961.2188
| 52
|
white
| 39.796875
| 69
| 0.633911
| 0.531982
| 4
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 10
| 125
| 13.5
| 134
| 14
| 39.89844
| 146
| 1.899902
| 10.798828
| 2.899902
| 146
| 7.319336
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
63.17599
|
female
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 9
| 30,752
| 20,501.6094
| 23,598.2812
| 46.5
|
white
| 46.59375
| 79
| 0.094986
| 0.037994
| 6
| 0
| 0
|
yes
| 0.25
| 0.15
|
dnr after sadm
| 6
| 69
| 37.59375
| 120
| 40
| 33.19531
| 134.6875
| 2.699707
| 1.399902
| 3
| 130
| 7.449219
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 9
| 1
|
62.004
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 9
|
under $11k
| 0
| 6,033
| 3,833.4531
| 4,658.6875
| 14
|
black
| 15.798828
| 29
| 0.905884
| 0.840942
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 6
| 141
| 8.5
| 65
| 20
| 36.79688
| null | null | 0.5
| 1.599854
| 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,324
| 0
|
60.44098
|
male
| 1
| 4
|
Coma
|
Coma
| 1
| 10
|
under $11k
| 100
| 10,197
| 6,800.8477
| 7,567.32812
| 38
|
white
| 39.09375
| 48
| 0.008999
| 0.003
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 3
| 36
| 11.5
| 72
| 22
| 34
| 188.5625
| 2.199707
| 0.399963
| 0.799927
| 135
| 7.509766
| null | null | null | null | null |
<2 mo. follow-up
| 3.190918
| 4
| 1
|
69.50897
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 5
| null | 0
| 7,024
| 3,988.1426
| 5,060.19922
| 10
|
white
| 18
| 29
| 0.858887
| 0.767944
| 2
| 1
| 0
|
no
| null | null |
no dnr
| 4
| 116
| 13.298828
| 81
| 20
| 37.89844
| null | null | null | 1.899902
| 134
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,322
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.